Document:

EX-4.12

 Exhibit 4.12 

THIS WARRANT AND THE SECURITIES THAT MAY BE PURCHASED PURSUANT TO THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 BLOOM ENERGY CORPORATION 

AGREEMENT AND WARRANT TO PURCHASE SERIES F PREFERRED STOCK 

Effective Date: July 1, 2014 

Void After: July 1, 2021 

This Agreement and Warrant to Purchase Series F Preferred Stock (this “Agreement” or “Warrant”) certifies that, for value
received, PE12PXVC (US DIRECT) LTD., or any permitted transferee (the “Holder”), is entitled, subject to the terms set forth below, to purchase from Bloom Energy Corporation, a Delaware corporation (the “Company”), up to 372,074
shares of Series F Preferred Stock of the Company (“Series F Preferred Stock”), upon surrender of this Warrant, at the principal office of the Company referred to below, with the subscription form attached hereto duly executed, and
simultaneous payment therefor, as hereinafter provided, of the aggregate Exercise Price (as defined below). The Exercise Price and the number of shares of Series F Preferred Stock purchasable hereunder are subject to adjustment as provided herein.

 1. Number of Shares. Subject to any adjustments pursuant to Section 11 herein, this Warrant may be exercised, in whole
or in part, for up to 372,074 shares of Series F Preferred Stock (the “Warrant Shares”). 
 2. Exercise Price.
Subject to any adjustments pursuant to Section 11 herein, the per share purchase price of the Series F Preferred Stock (the “Exercise Price”) for which this Warrant may be exercised shall be $18.52. 

3. Exercise of Warrant. 

3.1 Time of Exercise. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, at
any time or from time to time prior to 5:00 p.m. (Pacific Standard Time) on July 1, 2021 (the “Expiration Date”). 

Notwithstanding the foregoing, unless the Holder provides the Company with prior written notice to the contrary, this Warrant shall terminate
immediately prior to the closing of (i) a merger, consolidation, amalgamation or similar transaction of the Company with or into any other corporation or corporations in which the stockholders of the Company immediately prior to such
transaction shall own, immediately thereafter, less than fifty percent (50%) of the voting securities of the surviving corporation or its parent or (ii) a sale of all or substantially all of the assets of the Company (each a “Change
of Control Event”). The Company shall give the Holder written notice of a Change of Control Event not later than thirty (30) days prior to the closing of such Change of Control Event. 

  

					
		  		  	

 3.2 Method of Exercise. The exercise shall be effected by (a) the surrender of this
Warrant at the principal office of the Company as set forth in Section 12.6 (or such other office or agency of the Company as may be designated by notice in writing to the Holder at the address of the Holder appearing on the books of the
Company), (b) delivery of the Notice of Exercise attached hereto as Exhibit A (unless the Holder is exercising by means of a “net exercise” as provided for in Section 4 below, in which case the Holder shall deliver the Net
Exercise Notice attached hereto as Exhibit B (the “Net Exercise Notice”)), and (c) unless payment of the Exercise Price is made pursuant to a “net exercise” as provided under Section 4 below, payment of the
Exercise Price in cash, check or wire transfer of immediately available funds. 
 3.3 Effect of Exercise. This Warrant (or the
portion thereof exercised) shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise as provided above, and the Holder shall be treated for all purposes as the holder of record of
such Warrant Shares as of the close of business on such date. The Company, at its expense, shall, within three (3) business days after exercise, issue and deliver to the Holder (i) a certificate or certificates for the number of Warrant Shares
issuable upon such exercise and, (ii) unless this Warrant shall have expired or been exercised in full, a new warrant representing the right to acquire the number of Warrant Shares represented by the surrendered Warrant, if any, that shall not have
been exercised. 
 4. Net Exercise. 

4.1 Net Issue Exercise. In lieu of exercising this Warrant via payment by cash, check or wire transfer, the Holder may elect to receive
shares equal to the value of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with the completed Net Exercise Notice indicating the Holder’s election to exercise
this Warrant by means of a “net exercise,” in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula: 

X = Y (A - B)  
 A 

 

							
	Where	  	X        	  	=	  	the number of Warrant Shares to be issued to the Holder.
				
		  	Y	  	=	  	the number of Warrant Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised (at the date of such calculation).
				
		  	A	  	=	  	the fair market value (as determined below) of one Warrant Share (at the date of such calculation).
				
		  	B	  	=	  	the Exercise Price (as adjusted to the date of such calculation).

 If the above calculation results in a negative number, then no shares of Common Stock shall be issued or
issuable upon exercise of this Warrant. 

  

					
		  	-2-	  	

 4.2 Fair Market Value. For purposes of this Section 4, the “fair market
value” of one Warrant Share shall be determined by the Company’s Board of Directors in good faith which determination shall take in account any factors that the Company’s Board of Directors (the “Board”) deems relevant,
including, without limitation, any independent third party valuation but, for the avoidance of doubt, without giving effect to lack of control or lack of marketability; provided however, that if the time of exercise coincides with the Company’s
underwritten initial public offering, the “fair market value” shall be the price at which the Company’s Common Stock are sold at such public offering, and further provided, that where there exists a public market for the Warrant
Shares at the time of such exercise, the “fair market value” per Warrant Share shall be the average of the closing prices of the Warrant Shares on any such exchange on which the Warrant Shares is listed, whichever is applicable, for the
twenty-one (21) trading days prior to the date of the delivery of the Net Exercise Notice. 
 5. No Fractional Shares or
Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall, within three
(3) business days after exercise, make a payment to the Holder, via cash, check or wire transfer of immediately available funds, equal to the Exercise Price multiplied by such fraction computed to the nearest whole cent less the prorated
Exercise Price for such fractional share. 
 6. No Rights as Stockholder. Until the Warrant shall have been exercised as
provided herein, solely by virtue of this Warrant, the Holder shall not be entitled to vote or receive dividends or be deemed the holder of Series F Preferred Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted
to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive dividends or subscription rights or otherwise. Nothing contained in this Warrant shall be construed as imposing any liabilities on the
Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or creditors of the Company. 

7. Transfer of Warrant; Registration Rights. 

7.1 Transferability of Warrant. Subject to Section 7.2, this Warrant and all rights hereunder are transferable, in whole or in
part, upon the books of the Company by the Holder in person or by duly authorized attorney, and a new warrant shall be made and delivered by the Company, of the same tenor and date as this Warrant but registered in the name of one or more
transferees, upon surrender of this Warrant, duly endorsed, to the office or agency of the Company described in Section 3.2. All expenses (other than stock transfer taxes) and other charges payable in connection with the preparation, execution
and delivery of the new warrants pursuant to this Section 7.1 shall be paid by the Company. 
 7.2 Company Consent to Transfers.
Notwithstanding anything to the contrary set forth in Section 7.1, Holder may not transfer this Warrant, or any rights hereunder, prior to an initial public offering of the Company’s common stock without the prior written consent of the
Company, such consent not to be unreasonably withheld or delayed. 

  

					
		  	-3-	  	

 Notwithstanding the foregoing, the written consent of the Company will not be required and the
Holder shall only be required to provide the Company with prior written notice of any sale, transfer or other disposition of this Warrant prior to an initial public offering of the Company’s Common Stock if the sale, transfer or other
disposition is to (i) an “Affiliate” (as such term is defined in Rule 144(a) promulgated under the Securities Act, which for purposes of this Agreement shall be deemed to include any direct or indirect partner or other equityholder of
the Holder and shall include any investment entity under common management with the Holder) of the Holder, (ii) to the direct or indirect partners or retired partners of the Holder, if the Holder is a partnership, (iii) to the direct or
indirect shareholders of the Holder, if the Holder is a corporation, or (iv) to the direct or indirect members of the Holder, if the Holder is a limited liability company. 

7.3 Register. The Company will maintain a register (the “Warrant Register”) containing the name and address of the Holder.
The Holder of this Warrant may change its address as shown on the Warrant Register by written notice to the Company requesting such change. Any notice or written communication required or permitted to be given to the Holder may be delivered or given
by mail to the Holder as shown on the Warrant Register and at the address shown on the Warrant Register. 
 8. Representations and
Warranties of the Holder and Restrictions on Transfer Imposed by the Securities Act. 
 8.1 Representations and Warranties by the
Holder. The Holder hereby represents and warrants to the Company as follows: 
 (a) The Holder has full legal capacity, power and
authority to execute and deliver this Agreement and to perform its obligations hereunder. This Agreement is a valid and binding obligation of the Holder, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other
laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. 

(b) The Warrant and the Warrant Shares are being acquired for the Holder’s own account, for investment and not with a view to, or for
resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act or any state Blue Sky laws. 

(c) The Holder understands that the Warrant and the Warrant Shares have not been registered under the Securities Act by reason of their
issuance in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act pursuant to Section 4(2) thereof, that the Company has no present intention of registering the Warrant or the Warrant Shares, that
the Warrant and the Warrant Shares must be held by the Holder indefinitely, and that the Holder must therefor bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Securities Act or
is exempt from registration. 

  

					
		  	-4-	  	

 (d) The Holder agrees that it will not offer, sell or otherwise dispose of this Warrant or any
Warrant Shares to be issued upon exercise hereof except under circumstances which will not result in a violation of the Securities Act or any state securities law. This Warrant and all Warrant Shares issued upon exercise of this Warrant shall be
stamped or imprinted with legends in substantially the following form: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR
TRANSFERRED UNLESS (I) THERE IS AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH OFFER, SALE OR TRANSFER OR (II) THERE IS AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT EXEMPTIONS FROM THE REGISTRATION, QUALIFICATION AND
PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE STATE SECURITIES LAWS FOR SUCH OFFER, SALE OR TRANSFER ARE AVAILABLE. 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD FOLLOWING THE EFFECTIVE DATE OF THE COMPANY’S INITIAL
UNDERWRITTEN PUBLIC OFFERING AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. 

(e) During the negotiation of the transactions contemplated herein, the Holder and its representatives and legal counsel have been afforded
full and free access to corporate books, financial statements, records, contracts, documents, and other information concerning the Company and to its offices and facilities, have been afforded an opportunity to ask such questions of the
Company’s officers, employees, agents, accountants and representatives concerning the Company’s business, operations, financial condition, assets, liabilities and other relevant matters as they have deemed necessary or desirable, and have
been given all such information as has been requested, in order to evaluate the merits and risks of the prospective investments contemplated herein. 

(f) The Holder and its representatives have been solely responsible for the Holder’s own “due diligence” investigation of the
Company and the Company’s management and business, for its own analysis of the merits and risks of this investment, and for its own analysis of the fairness and desirability of the terms of the investment. In taking any action or performing any
role relative to the arranging of the proposed investment, the Holder has acted solely in its own interest, and the Holder (or any of its agents or employees) has not acted as an agent of the Company. The Holder has such knowledge and experience in
financial and business matters that the Holder is capable of evaluating the merits and risks of the purchase of the Warrant pursuant to the terms of this Agreement and of protecting the Holder’s interests in connection therewith. 

  

					
		  	-5-	  	

 (g) The Holder is an “accredited investor” as defined in Rule 501 of the Securities
Act. 
 (h) The Holder understands that it has had the opportunity to review with its own tax advisors the federal, state, local and
foreign tax consequences of this investment and the transactions contemplated by this Agreement. It understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the
transactions contemplated by this Agreement. 
 9. [Reserved]. 

10. Lost Documents. Upon receipt by the Company of evidence of the loss, theft, destruction or mutilation of, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will make and deliver to the Holder, in lieu of this Warrant, a new Warrant of the same series and of like tenor of this Warrant. 

11. Adjustments. The number of shares purchasable hereunder are subject to adjustment from time to time as follows: 

11.1 Reorganization, Reclassification, Merger or Conveyance. If any capital reorganization or reclassification of the capital stock of
the Company shall be effected in such a way that holders of Series F Preferred Stock shall be entitled to receive stock, securities or assets with respect to or in exchange for Series F Preferred Stock (including, for the avoidance of doubt, in the
event of an initial public offering of the Company’s common stock), or in the event the Company (or any such other corporation) merges with or into another corporation or conveys all or substantially all of its assets to another corporation and
this Warrant does not terminate in accordance with the, provisions of Section 3.1 above, then, as a condition of such reorganization, reclassification, merger or conveyance, lawful and adequate provisions shall be made whereby this Warrant
shall remain outstanding upon the terms and conditions specified herein and shall thereafter be automatically (and without further action) exercisable for (in lieu of the Warrant Shares immediately theretofore receivable upon the exercise of the
Warrant) such shares of stock, securities or assets (including cash) as may be issued or payable with respect to or in exchange for the number of Warrant Shares immediately theretofore so receivable, in connection with such reorganization,
reclassification, merger or conveyance. In any such case, the Company should ensure that the rights and interests of the Holder hereunder will not be disproportionately adversely affected relative to the other holders of the Company’s Series F
Preferred Stock. 
 11.2 Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant, or any portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities of the same class, the Exercise Price for such securities shall
be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination and the number of the securities as to which purchaser rights under this Warrant exist shall be increased or decreased
proportionately in accordance with such split subdivision or combination, in each case such that, following any such split subdivision or combination, Holder shall be entitled to purchase the number of Common Stock which Holder would have owned or
otherwise been entitled to receive in respect of shares of Common Stock subject to this Warrant after such date, had this Warrant been exercised immediately prior to such date. 

  

					
		  	-6-	  	

 11.3 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment
pursuant to this Section 11, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Secretary of the Company for filing in the Company’s records and to the
Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of the Holder, furnish or cause to be
furnished to the Holder a like certificate setting forth: (a) such adjustments and readjustments; (b) the Exercise Price at the time in effect; and (c) the number of shares and the amount, if any, of other property that at the time
would be received upon the exercise of the Warrant. No such adjustment or change shall compel immediate exercise of this Warrant or otherwise affect the Expiration Date of this Warrant. 

11.4 Other Adjustments (No Impairment). If any change in the Warrant Shares or any other event occurs as to which the other provisions
of this Section 11 are not strictly applicable or if strictly applicable would not fairly protect the purchase rights of the Holder in accordance with such provisions, then the Company shall make an adjustment in the number and class of shares
available under the Warrant, the Exercise Price or the application of such provisions, so as to protect such purchase rights as aforesaid. 

12. General Provisions. 

12.1 Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware, excluding that body of law
relating to conflict of laws. 
 12.2 Consent to Jurisdiction. Each of the parties hereto irrevocably submits to the exclusive
jurisdiction of the Court of Chancery of the State of Delaware or, if such Court of Chancery shall lack subject matter jurisdiction, the Federal courts of the United States of America located in the County of New Castle, Delaware, for the purposes
of any suit, action or other proceeding arising out of this Agreement or any of the Transactions. Each of the parties hereto further agrees that service of any process, summons, notice or document by U.S. registered mail to such party’s
respective address set forth in Section 12.6 shall be effective service of process for any action, suit or proceeding in Delaware with respect to any matters to which it has submitted to jurisdiction as set forth above in the immediately
preceding sentence. Each of the parties hereto irrevocably and unconditionally waives any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the Transactions in the Court of Chancery of the State of
Delaware or the Federal courts of the United States of America located in the County of New Castle, Delaware, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or
proceeding brought in any such court has been brought in an inconvenient forum. 
 12.3 Waiver of Jury Trial. THE PARTIES HEREBY
WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN

  

					
		  	-7-	  	

 
CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS SECTION 12.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG
THE PARTIES IRREVOCABLY TO WAIVE TRIAL BY JURY AND THAT ANY ACTION OR PROCEEDING WHATSOEVER AMONG THEM RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY SHALL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING
WITHOUT A JURY. 
 12.4 Survival. The representations, warranties, covenants and agreements made herein shall survive the execution
of this Agreement and the exercise of this Warrant. 
 12.5 Successors and Assigns. Except as otherwise expressly provided herein,
the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

12.6 Notices, etc. All notices and other communications required or permitted hereunder shall be in writing and shall be sent via
facsimile, overnight courier service or mailed by certified or registered mail, postage prepaid, return receipt requested, addressed or sent (a) if to the Holder, at the address or facsimile number of the Holder set forth below such
party’s name on the signature page hereto, or at such other address or number as the Holder shall have furnished to the Company in writing, or (b) if to the Company, at 1299 Orleans Dr., Sunnyvale, CA 94089, facsimile: (408) 543-1501,
attention: Chief Executive Officer or at such other address or number as the Company shall have furnished to the Holder in writing. 
 All
such notices and communications shall be effective (a) when sent by Federal Express or other overnight service of recognized standing, on the business day following the deposit with such service; (b) when mailed, by registered or certified
mail, first class postage prepaid and addressed as aforesaid through the United States Postal Service or Canada Post, four days after being deposited in the mail; (c) when delivered by hand, upon delivery; and (d) when faxed, upon
confirmation of receipt. 
 12.7 Amendments. This Warrant may be amended and the observance of any term of this Warrant may be waived
only with the written consent of the Company and the Holder. 
 12.8 Severability. In case any provision of this Agreement shall be
declared invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. Upon such determination that any term or other provision is invalid, illegal or
incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the Transactions are consummated
as originally contemplated to the fullest extent possible. 
 12.9 Counterparts. This Agreement may be executed in any number of
counterparts each of which shall be an original, but all of which together shall constitute one instrument. 

  

					
		  	-8-	  	

 IN WITNESS WHEREOF, the Company and the Holder have caused the Warrant to be executed as
of the effective date of this Warrant set forth above. 
  

			
	BLOOM ENERGY CORPORATION
		
	By:	 	/s/ William H. Kurtz
		 	Name: William H. Kurtz
		 	Title: Chief Financial and Commercial Officer

  

			
	 AGREED AND ACCEPTED:
  

	PE12PXVC (US DIRECT) LTD.
		
	By:	 	/s/ David Goerz
	Name:	 	David Goerz
	Title:	 	Director
	Address:	 	 #1100 – 10830 Jasper Avenue
 Edmonton,
AB T5J 2B3

  

					
		  		  	

 EXHIBIT A 

NOTICE OF EXERCISE 
 To: BLOOM ENERGY
CORPORATION 
 (1) The undersigned hereby elects to purchase
             shares of Series F Preferred Stock (“Series F Preferred Stock”) of Bloom Energy Corporation pursuant to the terms of the attached Agreement and Warrant to
Purchase Series F Preferred Stock (the “Warrant”) for an aggregate Exercise Price of              , and tenders herewith payment of the Exercise Price for such shares in
full in the following manner:                      . 

(2) The undersigned hereby confirms and acknowledges that the representations and warranties set forth in Section 8 of the Warrant remain
true and correct concerning the Holder as of the date hereof, that the shares of Series F Preferred Stock are being acquired solely for the account of the undersigned and not as a nominee for any other party, and for investment, and that the
undersigned will not offer, sell, or otherwise dispose of any such shares of Series F Preferred Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. 

(3) Please issue a certificate or certificates representing said shares of Series F Preferred Stock in the name of the undersigned or in such
other name as is specified below. A new warrant evidencing the remaining shares of Warrant Shares covered by the Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. 

 

	
	PE12PXVC (US DIRECT) LTD.
	
	   

	Print Name

  

	
	   

	Signature

  

	
	   

	Title

  

	
	   

	Date

  

					
		  		  	

 EXHIBIT B 

NET EXERCISE NOTICE 
 To: BLOOM ENERGY
CORPORATION 
 (1) The undersigned hereby elects to convert the attached Warrant into
             shares of Series F Preferred Stock (“Series F Preferred Stock”) of Bloom Energy Corporation pursuant to the terms of the attached Agreement and Warrant to
Purchase Series F Preferred Stock (the “Warrant”) for an aggregate Exercise Price of              , in the form of a cashless exercise in accordance with Section 4 of
the Warrant. 
 (2) In converting such Warrant, the undersigned hereby confirms and acknowledges that the representations and warranties set
forth in Section 8 of the Warrant remain true and correct concerning the Holder as of the date hereof, that the shares of Series F Preferred Stock are being acquired solely for the account of the undersigned and not as a nominee for any other
party, and for investment, and that the undersigned will not offer, sell, or otherwise dispose of any such shares of Series F Preferred Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended,
or any state securities laws. 
 (3) Please issue a certificate or certificates representing said shares of Series F Preferred Stock in the
name of the undersigned or in such other name as is specified below. A new warrant evidencing the remaining shares of Warrant Shares covered by the Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth
below. 
  

	
	PE12PXVC (US DIRECT) LTD.
	
	   

	Print Name

  

	
	   

	Signature

  

	
	   

	Title

  

	
	   

	DateEX-4.13

 Exhibit 4.13 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. 

WARRANT TO PURCHASE PREFERRED STOCK 

Issuer:                        BLOOM
ENERGY CORPORATION, a Delaware corporation 
 Number of Shares:    7,764 Shares (or as otherwise determined in Section 1 below) 

Class of Stock:          Series G Preferred Stock, $ .0001 par value 

Exercise Price:          $25.76 per Share 

Issue Date:                December 31, 2012 

Expiration Date:       The tenth anniversary of the Issue Date. 

THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for other good and valuable consideration, including the execution and
delivery of that certain Master Loan and Security Agreement No. BLOOX, dated as of December 31 , 2012, (the “Loan Agreement” and each loan thereunder, a “Loan”), this Warrant is issued to ATEL VENTURES, INC., in its capacity as
Trustee for its assignee affiliated funds identified in that certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants dated as of January 1,2007, as amended by Amendment No. 1 dated as of March 15,2010, and as may be
further amended and restated from time to time, and deemed effective as of July 20,2004 (“Holder”), by BLOOM ENERGY CORPORATION, a Delaware corporation (the “Company”). 

1. ISSUANCE. 
 Subject to
the terms and conditions hereinafter set forth, the Holder is entitled upon surrender of this Warrant and the duly executed subscription form annexed hereto as Appendix 1, at the office of the Company, 1299 Orleans Drive, Sunnyvale, CA 94089, or
such other office as the Company shall notify the Holder of in writing, to purchase from the Company up to 7,764 shares of fully paid and non-assessable shares (the “Shares”) of the Company’s Series G Preferred Stock, $.0001 par value
per share (the “Series G Preferred Stock”), at a purchase price per Share of $25.76 (the “Exercise Price”). This Warrant may be exercised in whole or in part at any time and from time to time until 5:00 PM, Pacific time, on the
Expiration Date set forth above, and shall be void thereafter. Until such time as this Warrant is exercised in full or expires, the Exercise Price and the Shares are subject to adjustment from time to time as hereinafter provided. 

2. EXERCISE 
 (a)
Method of Exercise. Holder may exercise this Warrant by delivering this Warrant, together with a duly executed Notice of Exercise in substantially the form attached as Appendix 1 hereto, to the principal office of the Company. Unless
Holder is exercising the conversion right set forth in Section 2(b), Holder shall also deliver to the Company a check for the aggregate Exercise Price for the Shares being purchased. 

  
 1 

 (b) Conversion Right. In lieu of exercising this Warrant as specified in
Section 2(a), Holder may from time to time convert this Warrant, in whole or in part, into a number of Shares determined as follows: 
  

			
	 X= Y(A-B)    

A

		
	 where:
	  	X = the number of Shares to be issued to the Holder.
		
		  	Y= the number of Shares with respect to which this
      Warrant is being exercised.
		
		  	 A= the Fair Market Value (as determined pursuant to

      Section 2 (c) below) of one Share.

		
		  	B= the Exercise Price.

 (c) Fair Market Value. 

(i) If shares of Common Stock are traded on a nationally recognized securities exchange or over the counter market, the fair market value of
one Share shall be the average closing price of a share of Common Stock over the five day trading period immediately preceding the date of Holder’s Notice of Exercise to the Company (or such lesser number of trading days as the stock has been
publicly traded). Notwithstanding the foregoing, in the event this Warrant is exercised in connection with the Company’s initial public offering of Common Stock, the fair market value per share shall be the product of (i) the per share
offering price to the public of the Company’s initial public offering, and (ii) the number of shares of Common Stock into which each share of Series G Preferred Stock is convertible at the time of exercise. 

(ii) If shares of Common Stock are not traded on a nationally recognized securities exchange or over the counter market, the Board of
Directors of the Company shall determine the fair market value of a share of Common Stock in its reasonable good faith judgment. The foregoing notwithstanding, if Holder advises the Board of Directors in writing that Holder disagrees with such
determination, then the Company and Holder shall promptly agree upon a reputable investment banking firm to undertake such valuation. If the valuation of such investment banking firm is greater than that determined by the Board of Directors by five
percent (5%) or more, then all fees and expenses of such investment banking firm shall be paid by the Company. In all other circumstances, such fees and expenses shall be paid by Holder. The determination of any such investment banking firm
shall be conclusive in any event. 
 (d) Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this
Warrant, the Company shall deliver to Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new Warrant representing the right to purchase the Shares not so acquired. 

  
 2 

 (e) Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, on surrender
and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor. 

(f) Assumption on Sale, Merger, or Consolidation of the Company. 

(i) “Acquisition”. For the purpose of this Warrant, “Acquisition” means any sale, transfer, exclusive license, or
other disposition of all or substantially all of the assets of the Company, or any acquisition, reorganization, consolidation or merger of the Company where the holders of the Company’s outstanding voting equity securities immediately prior to
the transaction beneficially own less than 50.01% of the outstanding voting equity securities of the surviving or successor entity immediately following the transaction, or a reverse triangular merger in which the Company survives as a wholly owned
subsidiary of the acquiring company and the holders of the Company’s outstanding voting equity securities prior to the reverse triangular merger remain the same. 

(ii) Treatment of Warrant at Acquisition. 

(A) Holder agrees that, in the event of an Acquisition in which the sole consideration is cash, either (1) Holder shall exercise its
conversion or purchase right under this Warrant and such exercise will be deemed effective immediately prior to the consummation of such Acquisition, or (2) if Holder elects not to exercise this Warrant, this Warrant will expire upon the
consummation of such Acquisition. The Company shall provide the Holder with written notice of its request relating to the foregoing (together with such reasonable information as the Holder may request in connection with such contemplated Acquisition
giving rise to such notice), which is to be delivered to Holder not less than ten (10) days prior to the closing of the proposed Acquisition. In the event that, on the date of the Acquisition described in this Section 2(f)(ii)(A) the Fair
Market Value of one Share (or other security issuable upon the exercise hereof) as determined in accordance with Section 2( c) above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically be deemed on
and as of such date to be converted pursuant to Section 2(b) above as to all Shares (or such other securities) for which it shall not previously have been exercised or converted, and the Company shall promptly deliver a certificate representing
the Shares (or such other securities) issued upon such conversion to the Holder. 
 (B) Holder agrees that, in the event of an Acquisition
that is a sale of all or substantially all of the Company’s assets (and only its assets) (an “Asset Sale”), either (1) Holder shall exercise its conversion or purchase right under this Warrant and such exercise will be deemed
effective immediately prior to the consummation of such Acquisition or (2) if Holder elects not to exercise this Warrant, this Warrant will continue until the Expiration Date if the Company continues as a going concern following the closing of
such Asset Sale. The Company shall provide the Holder with written notice of its request relating to the foregoing (together with such reasonable information as the Holder may request in connection with such contemplated Acquisition giving rise to
such notice), which is to be delivered to Holder not less than ten (10) days prior to the closing of the proposed Asset Sale. 

  
 3 

 (C) Holder agrees that upon the closing of any Acquisition (other than those described in
(A) and (B) of this Section 2(f)(ii), including Acquisitions in which the sole consideration is shares of a class or series of stock of a company that is privately or publicly traded, or any combination of cash or such shares of
stock, the Company shall either: 
 (1) cause the successor entity to assume the obligations of this Warrant, and this Warrant shall be
exercisable for the same securities and property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and its subsequent
closing (in such instance, the Warrant Price and/or numbers of Shares shall be adjusted accordingly), or 
 (2) purchase this Warrant on
the closing date of the Acquisition for an amount in cash equal to the greater of (i) the product of (A) the number of Shares issuable upon exercise of the unexercised portion of this Warrant, multiplied by (B) the excess (if any) of
the Fair Market Value of a Warrant Share over the Exercise Price or (ii) three times (3x) the Exercise Price less the Exercise Price. The Fair Market Value of a Warrant share shall be determined as set forth in Section 2(c). 

(g) Conversion or Redemption of Series G Preferred Stock. Should all of the Company’s Series G Preferred Stock be, or if
outstanding would be, at any time prior to the expiration of this Warrant or any portion thereof, redeemed or converted into shares of the Company’s Common Stock in accordance with Section 4 of the Charter, then this Warrant shall become
immediately exercisable prior to such event for that number of shares of the Common Stock that would have been received if this Warrant had been exercised in full and the Series G Preferred Stock received thereupon had been simultaneously converted
immediately prior to such event, and the Exercise Price shall immediately be adjusted to equal the quotient obtained by dividing (x) the aggregate Exercise Price of the maximum number of shares of Series G Preferred Stock for which this Warrant
was exercisable immediately prior to such conversion or redemption, by (y) the number of shares of Common Stock for which this Warrant is exercisable immediately after such conversion or redemption. For purposes of the forgoing, the
“Charter” shall mean the Amended and Restated Certificate of Incorporation as amended and /or restated and effective immediately prior to the redemption or conversion of all of the Company’s Series G Preferred Stock. 

3. ADJUSTMENTS. 
 (a)
Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on the outstanding shares of Series G Preferred Stock, payable in Common Stock or other securities, then upon exercise of this Warrant, for each Share acquired, Holder
shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record as of the date the dividend occurred. If the outstanding Series G Preferred Stock is
subdivided into a greater number of shares, the Exercise Price shall be proportionately decreased and the number of Shares shall be proportionately increased. 

(b) Reclassification, Exchange or Substitution. Upon any reclassification, exchange, substitution, or other event that results in a
change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder
would have received for the Shares if this Warrant had been exercised immediately before 

  
 4 

 
such reclassification, exchange, substitution, or other event. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant
shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 3 including, without limitation, adjustments to the Exercise Price and to the number of securities or
property issuable upon exercise of the new Warrant. The provisions of this Section 3(b) shall similarly apply to successive reclassifications, exchanges, substitutions, or other events. 

(c) Adjustments for Combinations, Etc. If the outstanding shares of Series G Preferred Stock are combined or consolidated, by
reclassification or otherwise, into a lesser number of shares, the Exercise Price shall be proportionately increased and the number of Shares shall be proportionately decreased. 

(d) No Impairment. The Company shall not, by amendment of the Charter or Bylaws, or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all
times in good faith assist in carrying out of all the provisions of this Section 3 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. 

(e) Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of this Warrant and the number of Shares to
be issued shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise or conversion of this Warrant, the Company shall eliminate such fractional Share interest by paying Holder an amount computed by
multiplying such fractional interest by the Fair Market Value (determined in accordance with Section 2(c) above) of one Share. 
 (f)
Certificate as to Adjustments. Upon each adjustment of the Exercise Price, number of Shares or class of security for which this Warrant is exercisable, the Company, at its expense, shall promptly compute such adjustment, and furnish Holder
with a certificate of its chief financial officer setting forth such adjustment and the facts upon which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Exercise Price, number of
Shares class of security for which this Warrant is exercisable in effect upon the date thereof and the series of adjustments leading to such Exercise Price, number of Shares and class of security. 

4. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 

(a) Representations and Warranties. The Company hereby represents and warrants to Holder as follows: 

(i) All Shares which may be issued upon the due exercise of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid
and non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws. 

  
 5 

 (ii) The Company covenants that it shall at all times cause to be reserved and kept available
out of its authorized and unissued shares such number of shares of its Preferred Stock and other securities as will be sufficient to permit the exercise in full of this Warrant and the conversion or exchange of such Preferred Stock into or for such
other securities. 
 (iii) The execution and delivery by the Company of this Warrant and the performance of all obligations of the Company
hereunder, including the issuance to Holder of the right to acquire the shares of Preferred Stock, have been duly authorized by all necessary corporate action on the part of the Company, and the Loan Agreement and this Warrant are not inconsistent
with the Company’s Charter or Bylaws, do not contravene any law or governmental rule, regulation or order applicable to it, do not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or
other instrument to which it is a party or by which it is bound, and the Loan Agreement and this Warrant constitute legal, valid and binding agreements of the Company, enforceable in accordance with their respective terms. 

(iv) No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state, Federal or
other governmental authority or agency is required with respect to the execution, delivery and performance by the Company of its obligations under this Warrant, except for the filing of notices pursuant to Regulation D under the 1933 Act and any
filing required by applicable state securities law, which filings will be effective by the time required thereby. 
 (b) Notice of
Certain Events. If the Company proposes at any time (a) to declare any dividend or distribution upon its Common Stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for
subscription pro rata to the holders of Common Stock any additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of its Common Stock; (d) to merge or consolidate with or
into any other corporation, or sell, lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up; or (e) offer holders of registration rights the opportunity to participate in an underwritten public
offering of the company’s securities for cash, then, in connection with each such event, the Company shall give Holder (1) at least 20 days prior written notice of the date on which a record will be taken for such dividend, distribution,
or subscription rights (and specifying the date on which the holders of securities of the Company shall be entitled to receive such dividend, distribution or rights) or for determining rights to vote, if any, in respect of the matters referred to in
(c) and (d) above; (2) in the case of the matters referred to in (c) and (d) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of securities
of the Company will be entitled to exchange their securities of the Company for securities or other property deliverable upon the occurrence of such event); and (3) in the case of the matter referred to in (e) above, the same notice as is
given to the holders of such registration rights. 
 (c) Information Rights. So long as the Holder holds this Warrant and/or any of
the Shares, the Company shall deliver to the Holder (i) promptly after mailing, copies of all notices or other written communications to the stockholders of the Company, (ii) if the subject Loan(s) under the Loan Agreement no longer are
outstanding, then upon Holder’s request, within one hundred and eighty (180) days after the end of each fiscal year of the Company, the annual audited financial statements of the Company certified by independent public accountants of
recognized standing and (iii) if the subject Loan(s) under the Loan 

  
 6 

 Agreement no longer are outstanding, then upon Holder’s request, within forty five (45) days after the
end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial statements; provided, however, that the Company shall have no obligation to provide financial statements pursuant to (iii) above at
any time when the per share purchase price of the equity securities sold in the Company’s latest bona fide equity financing with the purpose of raising capital is equal to or greater than two times the Exercise Price (as adjusted for any stock
splits, stock dividends or the like). Anything in this Agreement to the contrary notwithstanding, no Holder by reason of this Agreement shall have access to any trade secrets or classified information of the Company. The Company shall not be
required to comply with any information rights of hereunder in respect of any Holder whom the Company reasonably determines to be a competitor or an officer, employee, director or holder of more than ten percent (10%) of a competitor. Holder
acknowledges that the information received by them pursuant to this Warrant may be confidential and for its use only, and it will not use such confidential information in violation of the Exchange Act or reproduce, disclose or disseminate such
information to any other person (other than its employees or agents having a need to know the contents of such information, and its attorneys). 

(d) Registration Under Securities Act of 1933, as Amended. The Company agrees that the Shares shall be entitled to certain
registration rights (“Registration Rights”), as set forth in that certain Eighth Amended and Restated Registration Rights Agreement dated as of June 30, 2011, among the Company and the Company’s stockholders named therein, (as
may be amended, the “Registration Rights Agreement”). The Company agrees to amend the Registration Rights Agreement to make Holder a party thereto for such purpose. Failure to provide such Registration Rights to Holder within ninety
(90) days of the date of the first Loan under the Loan Agreement, shall, at Holder’s option, be an Event of Default under the Loan Agreement. Notwithstanding anything to the contrary in the Registration Rights Agreement, such registration
rights shall be pari passu with the rights of all other Holders, as defined therein, and the Company shall obtain the requisite prior written consent of the Holders to ensure Holder receives such pari passu registration rights. Upon becoming a party
to the Registration Rights Agreement, Holder agrees to be bound by the terms and conditions thereof. The Company represents and warrants to Holder that the Company’s execution, delivery and performance of the Registration Rights Agreement
(a) has been duly authorized by all necessary corporate action of the Company’s Board of Directors and stockholders, (b) does not and will not violate the Company’s Charter or Bylaws, each as amended, (c) does not and will
not violate or cause a breach or default (or an event which with the passage oftime or the giving of notice or both, would constitute a breach or default) under any agreement, instrument, mortgage, deed of trust or other arrangement to which the
Company is a party or to or by which it or any of its assets is subject or bound, and (d) does not require the approval, consent or waiver of or by any shareholder, registration rights holder or other third party which approval, consent or
waiver has not been obtained as of the date of issuance of this Warrant. 
 (e) Termination of Covenants. The covenants set forth in
Sections 4(b) and 4(c) shall terminate and be of no further force and effect after the closing of the Company’s first public offering of the Company’s Common Stock registered under the Securities Act of 1933, as amended, or an Acquisition.

  
 7 

 5. REPRESENTATIONS AND COVENANTS OF HOLDER. 

(a) Representations and Warranties. Holder hereby represents and warrants to the Company as follows: 

(i) The right to acquire Shares and the Common Stock issuable upon conversion of the Shares will be acquired for investment purposes and not
with a view to the sale or distribution of any part thereof, and Holder has no present intention of selling or engaging in any public distribution of the same in violation of the 1933 Act. 

(ii) Holder understands (A) that this Warrant, the Shares issuable upon exercise of this Warrant and the Common Stock issuable upon
conversion of the Shares are not registered under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant will be exempt from the registration and qualifications requirements
thereof, and (B) that the Company’s reliance on such exemption is predicated on the representations set forth in this Section 5. 

(iii) In no event will Holder make a disposition of any of Holder’s rights to acquire Shares or Shares issuable upon exercise of such
rights or the Common Stock issuable upon conversion of the Shares unless and until (i) Holder shall have notified the Company in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the applicable
terms and conditions of this Warrant, and (iii) if the Company request, Holder shall have furnished the Company with an opinion of counsel satisfactory to the Company and the Company’s counsel to the effect that (A) appropriate action
necessary for compliance with the 1933 Act has been taken, or (B) an exemption from the registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of
Holder’s rights to acquire Shares or Shares issuable on the exercise of such rights or the Common Stock issuable upon conversion of the Shares do not apply to transfers from the beneficial owner of any of the aforementioned securities to its
nominee or from such nominee to its beneficial owner, and shall terminate as to any particular share of Shares when (1) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with
such registration or (2) such security shall have been sold without registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to the Company at Holder’s request by the staff of the Securities
and Exchange Commission or a ruling shall have been issued to the Company at Holder’s request by such Commission stating that no action shall be recommended by such staff or taken by such Commission, as the case may be, if such security is
transferred without registration under the 1933 Act in accordance with the conditions set forth in such letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed
hereunder shall terminate, as hereinabove provided, the holder of a share of Shares then outstanding as to which such restrictions have terminated shall be entitled to receive from the Company, without expense to such holder, one or more new
certificates for the Warrant or for such shares of Shares not bearing any restrictive legend referring to 1933 Act registration or exemption. 

(iv) Holder has such knowledge and experience in financial and business matters and knowledge of the Company’s business affairs and
financial condition as to be capable of evaluating the merits and risks of Holder’s investment, and have the ability to bear the economic risks of Holder’s investment. 

(v) Holder understands that if the Company does not register with the Securities and Exchange Commission pursuant to Section 12 of the
1934 Act (the “1934 Act”), or file reports pursuant to Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when Holder desire to sell (i)

  
 8 

 
the rights to purchase Shares pursuant to this Warrant, or (ii) the Shares issuable upon exercise of the right to purchase, or (iii) the Common Stock issuable upon conversion of the
Shares, Holder may be required to hold such securities for an indefinite period. Holder also understand that any sale of Holder’s right to purchase Shares or Shares or Common Stock issuable upon conversion of the Shares, which might be made by
it in reliance upon Rule 144 under the 1933 Act may be made only in accordance with the terms and conditions of that Rule. 
 (vi) Holder
is an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D of the 1933 Act, as presently in effect. 

(vii) Holder’s domicile for purposes of state securities laws is in the State of California. 

(b) Lockup. Holder and each of Holder’s transferees agrees, in connection with the first registration of the Company’s
securities under the 1933 Act, upon the Company’s request or the request of the underwriters managing any underwritten offering of the Company’s securities, not to (a) lend, offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable for Common Stock (whether such shares or any such securities are then owned by Us or are thereafter acquired) or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of the Common Stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, without the Company’s prior
written consent or the prior written consent of such underwriters, as the case may be, for such period of time (not to exceed 180 days or such other period as may be requested by the Company or the underwriters to accommodate regulatory restrictions
on (i) the publication or other distribution of research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor
provisions or amendments thereto) from the effective date of such registration as the Company or the underwriters may specify; provided, however, that all (x) the Company’s officers and directors and (y) the Company’s
stockholders holding three percent (3%) or more of the Company’s total outstanding Common Stock (treating all the Company’s convertible, exercisable and exchangeable securities on an as-if converted to Common Stock basis) are bound by
agreements that are no less restrictive. The underwriters in connection with the Company’s initial public offering are intended third party beneficiaries of this Lock-Up Agreement and shall have the right, power and authority to enforce the
provisions hereof as though they were a party hereto. Holder agrees that the Company may instruct the Company’s transfer agent to place stop-transfer notations in its records to enforce the provisions of this Lock-Up Agreement until the end of
such period. 
 5. MISCELLANEOUS. 

(a) Automatic Conversion upon Expiration. In the event that, upon the Expiration Date, the Fair Market Value of one Share (or other
security issuable upon the exercise hereof) as determined in accordance with Section 2( c) above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be converted
pursuant to Section 2(b) above as to all Shares (or such other securities) for which it shall not previously have been exercised or converted, and the Company shall promptly deliver a certificate representing the Shares (or such other
securities) issued upon such conversion to the Holder. 

  
 9 

 (b) Legends. This Warrant and the Shares (and the securities issuable, directly or
indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form: 
 THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE
OFFERED, SOLD, PLEDGED OR TRANSFERRED UNLESS (I) THERE IS AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH OFFER, SALE OR TRANSFER OR (II) THERE IS AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT EXEMPTIONS FROM THE
REGISTRATION, QUALIFICATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE STATE SECURITIES LAWS FOR SUCH OFFER, SALE OR TRANSFER ARE AVAILABLE. 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD FOLLOWING THE EFFECTIVE DATE OF THE COMPANY’S INITIAL UNDERWRITTEN PUBLIC
OFFERING AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. 
 (c)
Compliance with Securities Laws on Transfer. This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance
with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation letters). The Company shall not require Holder to provide an opinion of counsel if the
transfer is to an affiliate of Holder or if (a) there is no material question as to the availability of current information as referenced in Rule 144(c), (b) Holder represents that it has complied with Rule 144( d) and (e) in
reasonable detail, (c) the selling broker represents that it has complied with Rule 144(f), and (d) the Company is provided with a copy of Holder’s notice of proposed sale. 

(d) Transfer Procedure. Subject to the provisions of Section 5(d), Holder may transfer all or part of this Warrant and/or the
Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) at any time to any affiliate of Holder, or to any other transferee by giving the Company notice of the portion
of the Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable). Holder agrees not to
transfer this Warrant to a competitor of the Company as determined in good faith by the Company’s Board of Directors. 
 (e)
Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally or sent by electronic facsimile transmission, express overnight courier service, or
mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as the case may be, in writing by the Company or such holder from time to time, but in all cases, unless
instructed in writing otherwise, the Company shall deliver a copy of all notices to Holder at 600 Montgomery Street, 9th Floor, San Francisco CA 94111, Attention: Associate General Counsel. 

  
 10 

 (f) Waiver. This Warrant and any term hereof may be changed, waived, discharged or
terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 

(g) Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either by
suit in equity and/or by action at law, including, but not limited to, an action for damages as a result of any such default, and/or an action for specific performance for any default where the non-defaulting party will not have an adequate remedy
at law and where damages will not be readily ascertainable. The defaulting party expressly agrees that it shall not oppose an application by the non-defaulting party or any other person entitled to the benefit of this Warrant requiring specific
performance of any or all provisions hereof or enjoining the defaulting party from continuing to commit any such breach of this Warrant. 

(h) Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the
party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees. 

(i) Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of California, without
giving effect to its principles regarding conflicts of law. 
 (j) Venue. All judicial proceedings arising in or under or related to
this Warrant may be brought in any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this Warrant, each party hereto generally and unconditionally: (i) consents to personal
jurisdiction in San Mateo County, State of California; (ii) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (iii) agrees not to assert any defense based on lack of jurisdiction or venue in the
aforesaid courts; and (iv) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Warrant. Service of process on any party hereto in any action arising out of or relating to this agreement shall be effective if
given in accordance with the requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall
limit the right of either party to bring proceedings in the courts of any other jurisdiction. 

  
 11 

 IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Preferred Stock to be
executed by its duly authorized representative as of the date first above written. 
  

			
	 COMPANY
 BLOOM ENERGY
CORPORATION

		
	By:	 	/s/ Martin J Collins
	Name:	 	Martin J Collins
	Title:	 	VP Corp Dev

  

			
	 HOLDER
 ATEL VENTURES, INC.,
Trustee

		
	By:	 	/s/ Paritosh K. Choksi
	Name:	 	Paritosh K. Choksi
	Title:	 	Executive Vice President

 ATEL LEGAL DEPARTMENT 

APPROVED 
 AS TO FORM

  

							
		  	BY:	  	

	  	

  
 12 

 APPENDIX 1 

NOTICE OF EXERCISE 
 1.
The undersigned hereby elects to purchase              shares of the
                     stock of BLOOM ENERGY CORPORATION pursuant to Section 2(a) of the attached Warrant, and tenders herewith payment of
the Exercise Price of such shares in full. 
 1. The undersigned hereby elects to convert the attached Warrant into Shares in the manner
specified in Section 2(b) of the attached Warrant. This conversion is exercised with respect to                  shares of the
                     Stock of BLOOM ENERGY CORPORATION. 

[Strike paragraph that does not apply.] 

2. Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified
below: 
  

					
		  	 	 	
		  	 (Name)
	 	
			
		  	 	 	
			
		  	 	 	
		  	 (Address)
	 	

 3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for
any other party and not with a view toward the resale or distribution thereof except in compliance with applicable securities laws. 
  

					
	 	  		  	 
	(Date)	  		  	(Signature)
	(Signature)	  		  	

  
 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]